Side-by-side comparison of AI visibility scores, market position, and capabilities
India event trading and prediction market platform at $25M annualized GMV growing 30% MoM; YC W22 $1M+ Java Capital/Soma Capital-backed targeting 50M Indian users for cricket and election outcome trading.
Better Opinions is an India-based event trading and prediction market platform — backed by Y Combinator (W22) with $1 million+ raised in a pre-seed round from Java Capital and Soma Capital — enabling Indian users to trade on real-world event outcomes (cricket match results, election outcomes, stock price movements, entertainment events) through a prediction market interface, operating at $25 million in annualized GMV with 30% month-over-month growth and targeting the nearly 50 million active Indian users who represent approximately 25% of all demat account holders in the country. Founded in 2021 and headquartered in India, Better Opinions operates in the intersection of online gaming and financial prediction markets that Indian regulators are actively defining under SEBI (Securities and Exchange Board of India) and the Ministry of Electronics and Information Technology.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.